REGENSCIENTIFIC receives CE-mark for Renú® soft tissue injectable implant
Implant indicated for lipoatrophy, vocal fold insufficiency, and soft tissue augmentation
Read MoreImplant indicated for lipoatrophy, vocal fold insufficiency, and soft tissue augmentation
Read MoreLow levels of vitamin D have long been identified as an unwanted hallmark of weight loss surgery, but now findings of a new Johns Hopkins study of more than 930,000 (more…)
Read MoreChemodenervation shown to slow HA filler degradation
Read MoreLumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announced that the company has completed the acquisition of Pollogen Ltd. “We are excited to (more…)
Read More150 International Surgeons from 22 Countries Converge in London to Celebrate Breast of British
Read MoreNew survey reveals Britons seek anti-aging treatments to stay competitive in work, reward themselves and maintain youthfulness
Read MoreKYBELLA® first FDA-approved non-surgical injection for submental fullness bolsters Allergan’s world-class facial aesthetics portfolio
Read MoreAllergan announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip...
Read More